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CHAPTER I
INTRODUCTION
Rationale for Dissertation
 Anion exchanger 1 (AEI), also known as band 3, is the most abundant inte-
gral membrane protein in the human erythrocyte (Fairbanks et al. 1971). Band 3 is 
composed of two structurally and functionally distinct domains (Steck et al. 1976). 
The transmembrane domain of band 3 (tdb3) is responsible for the exchange of 
chlorine and bicarbonate ions across the erythrocyte membrane (Cabantchik and 
Rothstein 1974), a process essential to CO2 excretion and acid-base balance regu-
lation in the blood (Crandall et al. 1981). The cytoplasmic domain of band 3 acts 
as an organizing center for numerous protein-protein interactions at the red blood 
cell membrane. Proteins that interact with cdb3 include membrane cytoskeleton 
components, glycolytic enzymes, hemoglobin, and hemichromes (Low 1986). Mu-
tations  in AE1 are associated with hereditary spherocytosis  (HS) (Delaunay 2002) 
and Southeast Asian ovalocytosis  (SAO) (Jarolim et al. 1991). The crystal struc-
ture of cdb3 (55-356) has been determined at the nonphysiological pH 4.8 (Zhang 
et al. 2000) and its  solution structure at pH 6.8 confirmed the packed dimer struc-
ture observed in the crystal structure (Zhou et al. 2005).
 Of the three mutations in the cytoplasmic domain that are associated with 
HS, only the Tuscaloosa variant (P327R) has been studied from the angle of struc-
tural biology (Zhou et al. 2007). The band 3 Fukuoka variant (G130R), like the 
P327R mutation, results in decreased protein 4.2 while having little effect on the 
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total band 3 content of the red blood cell. The G130R mutation is  located on the 
surface of helix 2, a region thought to be part of the ankyrin-binding interface. 
This dissertation study utilizes site-directed spin labeling (SDSL) paired with elec-
tron paramagnetic resonance (EPR) techniques in order to study the structural 
changes caused by the G130R mutation. This work has shown that EPR methods 
can be advantageous when studying small structural changes by providing infor-
mation on secondary structure and residue environment.
Erythrocyte Membrane Skeleton
Organization of the Erythrocyte Cytoskeleton
 The erythrocyte membrane skeleton is  well-studied and provides a model 
system for the study of protein-membrane interaction. The membrane skeleton is 
typically organized as a hexagonal lattice (Figure 1A) composed primarily of spec-
trin tetramers, formed by head-to-tail association of spectrin !" heterodimers 
(Morrow and Marchesi 1981). The ends of the spectrin tetramers form junctional 
complexes  with a number of proteins such as actin, protein 4.1, protein 4.9, tro-
pomyosin, and adducin (Figure 1B) (Bennett 1989).
 In addition to these associations, the erythrocyte cytoskeleton interacts with 
the red blood cell membrane through two multiprotein complexes. One of the 
complexes  occurs at the aforementioned junctional complex involving spectrin, 
actin, and protein 4.1. At this site, protein 4.1 creates another ternary complex with 
protein p55 and the transmembrane protein glycophorin C, binding the spectrin 
network to the erythrocyte membrane (Figure 1B). Protein 4.1 can also interact 
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with the dimeric form of the integral membrane protein band 3 and has binding 
sites for the transmembrane proteins Rh, Kell, and XK (Salomao et al. 2008). The 
other linkage to the erythrocyte membrane by attaching to two self-associating 
band 3 dimers through the scaffolding protein ankyrin (Bennett and Stenbuck 
1979). The band 3-ankyrin complex will be discussed in further detail later.
 A
B
(+) end
(-) end
Figure 1. Organization of the erythrocyte membrane cytoskeleton
A: Transmission electron micrograph of the erythrocyte cytoskeleton. Approximately six 
spectrin tetramers are cross-linked at  junctional nodes, forming a hexagonal lattice. (Liu 
et al. 1987)
B: The spectrin-actin junction. Short F-actin filaments join spectrin at the junctional 
nodes in A. The negative end of the actin filaments are blocked by tropomodulin whereas 
the positive end interacts with adducin. Nonmuscle tropomyosin lies along the length of 
the actin filaments. Protein 4.1 induces the spectrin-actin interaction and forms a complex 
with p55 and the transmembrane protein glycophorin C.
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Mechanical Properties of the Erythrocyte Cytoskeleton
 The main purpose of the red blood cell cytoskeleton is  to maintain the cell’s 
characteristic biconcave shape, a shape that allows the cell to undergo major shape 
deformations  in order to pass through capillaries without fragmenting. Due to 
these requirements, the erythrocyte membrane must be both highly deformable 
and extremely stable. Studies of pathologically and biochemically perturbed eryth-
rocyte membranes has shown that deformability and stability of the membrane are 
regulated independently by separate cytoskeletal components  (Chasis and Mohan-
das 1986). Spectrin’s structure plays an important role in maintaining this flexibil-
ity. Spectrin is  comprised of 106 amino acid triple helical segments that are con-
nected to adjacent segments via short nonhelical regions (Speicher and Marchesi 
1984). The folded stability of these repeats varies along the length of the protein 
and, together with the hinge region created by the linker, provides spectrin with 
flexibility along its length (MacDonald and Cummings 2004). Atomic force 
microscopy-related techniques have also shown the unfolding forces of the !-
helical repeats to be much lower than domains  containing "-folds, with the unfold-
ing process being cooperative in consecutive repeats (Rief et al. 1999; Law et al. 
2003).
 Aside from the intrinsic properties of the proteins, a number of outside fac-
tors effect the mechanical properties  of the red cell membrane. The rigidity of the 
cell during its deformation is influenced by intracellular calcium concentrations 
(Brody et al. 1995). Calcium is known to interact with the spectrin-protein 
4.1-actin complex as well as  the spectrin-ankyrin-band 3 complex, inducing de-
creased deformability (Takakuwa and Mohandas 1988, Liu et al. 2005). The study 
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of membrane abnormalities has shown that the bridging of the cytoskeleton to the 
lipid bilayer through ankyrin also plays a role in membrane stability. While not as 
pronounced as with spectrin disorders, abnormalities  in ankyrin reduce the mem-
brane shear elasticity of red blood cells (Waugh 1987).
Erythrocyte Cytoskeleton Disorders
 Hemolytic anemia is a state of increased red blood cell destruction. The 
disorders  of the red blood cell membrane that result in hemolytic anemia are pre-
dominantly hereditary in nature, though a few acquired defects  exist. A number of 
genetic mutations are associated with hereditary spherocytosis (HS) and will be 
discussed later. Hereditary elliptocytosis (HE) and hereditary poikilocytosis (HP) 
are two forms of the same disorder that only differ in their severity with HP being 
the more symptomatic of the two. A majority of the mutations leading to HE/HP 
are found in spectrin, with all spectrin mutations lying at or near the self-
association site of the !- and "-spectrin chains (Maillet et al. 1996). Southeast Asia 
Ovalocytosis (SAO) is a symptomless disorder that occurs in people from Papau 
New Guinea, the Philippines, and other neighboring countries. The mutation re-
sponsible results  in a gap of nine amino acids at the juncture between the trans-
membrane and cytoplasmic domains of band 3 (Jarolim et al. 1991).
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Structure and Function of Anion Exchanger 1
Topology and Function of AE1 Transmembrane Domain
 AE1, also known as band 3, is  the prototypical member of the SLC4 gene 
family, a family of three Cl-/HCO3- anion exchangers. The mechanism of anion 
exchange has  been studied using disulfonic stilbene derivatives since they inhibit 
anion permeability while having no effect on cations. One of the more potent di-
sulfonic stilbenes, DIDS, was  used to identify band 3 as the mediator of anion ex-
change (Cabantchik and Rothstein 1974). An analogue of DIDS, H2DIDS, was 
later used to support the ping-pong model for one-to-one exchange of anions 
across the plasma membrane by confirming the existence of two conformations 
dependent on the chloride concentration across  the membrane. In this model, there 
is  only one transport site that can face either the intracellular or extracellular 
space. When intracellular chloride is  increased in the presence of a constant extra-
cellular chloride concentration, more of the anion binding sites face outward, de-
tectable by an increase in H2DIDS inhibition (Furuya et al. 1984).
 The transmembrane domain of band 3 (tdb3) is  the domain responsible for 
this  physiological function. Located at the C-terminal end of band 3, tdb3 is  be-
lieved to contain 12-14 transmembrane regions (Figure 2) (Zhu et al. 2003). Fur-
ther studies have been performed to develop a model of how the transmembrane 
segments are organized relative to the dimer interface (Groves and Tanner 1999).
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Figure 2. Proposed topology of AE1 transmembrane domain
Putative topology of the AE1 transmembrane domain determined using cysteine-scanning 
mutagenesis and sulphhydryl specific chemistry. Arrows indicate proteolytic sites, the 
shading indicates the degree of biotin maleimide labeling, and an asterisk indicates a cys-
teine mutant was accessible to qBBR, showing that site to be exposed to the extracellular 
medium. This model displays thirteen transmembrane segments with another possible 
transmembrane segment between the ninth and tenth segments. (Zhu et al. 2003)
Structure and Function of AE1 Cytoplasmic Domain
 The cytoplasmic domain of band 3 (cdb3) serves as a major organization 
center for the red blood cell membrane. As an anchoring point, cdb3 interacts with 
a number of proteins including ankyrin (Bennett and Stenbuck 1980), protein 4.1 
(Pasternack et al. 1985), protein 4.2 (Korsgren and Cohen 1988), glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) (Beth et al. 1981, Rogalski et al. 1989), 
phosphofructokinase (PFK) (Jenkins et al. 1985), aldolase (Murthy et al. 1981), 
hemoglobin (Walder et al. 1984), and hemichromes (Waugh and Low 1985) (Fig-
ure 3). Band 3 is  also a substrate of the protein tyrosine kinase p72syk (Harrison et 
al. 1994).
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 Through these interactions band 3 is involved in many processes within the 
red blood cell, most notable of which is  its role in the mechanical properties of the 
erythrocyte membrane. Band 3 is  connected to the spectrin cytoskeleton in two 
separate macromolecular complexes (Salomao et al. 2008). The complex involving 
protein 4.1 has been described previously. The second complex involving ankyrin 
and protein 4.2 (Su et al. 2006) is the principle bridge between the erythrocyte cy-
toskeleton and the lipid bilayer. The interaction between ankyrin and cdb3 is es-
sential for the morphology and stability of the red blood cell membrane (Low et al. 
1991; Peters et al. 1996; Anong et al. 2006) and protein 4.2 may help stabilize this 
interaction (Rybicki et al. 1988). The cytoplasmic domain of band 3 also has 
shown a role in membrane deformability both through its interaction with the cy-
toskeleton and its own inherent flexibility (Mohandas et al. 1992; Uyesaka et al. 
1992; Blackman et al. 2001). Cdb3 plays an inhibitory role in glycolysis through 
its interaction GAPDH, PFK, aldolase, and hemoglobin. (Low et al. 1993; Weber 
et al. 2004; Campanella et al. 2005). In addition to these interactions, the anion ex-
changer activity of band 3 is modulated by the binding of factors  such as hemo-
globin and magnesium to cdb3 (Galtieri et al. 2002; Teti et al. 2002).
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Figure 3. Erythrocyte membrane-cytoskeleton connection
Ankyrin interacts with "-spectrin at the spectrin self-association site. Each ankyrin is ca-
pable of cross-linking two band 3 dimers. The association of ankyrin with band 3 is stabi-
lized by   protein 4.2. The cytoplasmic domain of band 3 also complexes with phos-
phofructokinase (PFK), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), aldolase, 
hemichrome, and hemoglobin at this junction.
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 Structural studies of cdb3 have revealed a compact symmetric dimer with 
N- and C-terminal tails  lacking secondary structure (Figure 4A). Each monomer 
contains 11 "-strands and 10 !-helices. Eight of the "-strands form into a "-sheet 
consisting of both parallel and antiparallel strands. Along with the first six helices, 
this  central "-sheet makes up the central globular domain of the cdb3 monomer. 
Two of the remaining "-strands spanning residues 175-185 form a "-hairpin loop 
while the last "-strand is  part of the dimerization arm. The dimerization arm is a 
largely helical segment at the C-terminal end of cdb3 and is connected to the 
globular domain by a short helix and loop segment (Figure 4B) (Zhang et al. 2000; 
Zhou et al. 2005). Loss of the "-hairpin loop makes a mutant that is has no affinity 
to ankyrin, identifying this  loop as necessary for the interaction with ankyrin 
(Chang and Low 2003). This  segment alone, however, is not sufficient for the 
binding of ankyrin. Antibodies  developed against residues 118-162 of cdb3 also 
inhibited the binding of ankyrin (Davis et al. 1989). A computational model of the 
cdb3-ankyrin complex has identified further areas possibly involved in the binding 
site with total of over 1,500Å2 of buried surface area (Michaely et al. 2002).
10
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 B
Figure 4. Structure of the cytoplasmic domain of human band 3
A: Crystal structure of cdb3 at pH 4.8. The cdb3 dimer is displayed in ribbon diagram 
colored based on secondary structure. The dimerization arms (304-357) are highlighted in 
cyan and purple.
B: Diagram of cdb3 monomer secondary structure. The cdb3 monomer includes 11 "-
strands and 10 !-helices. "-strands 1-4, 5, and 8-10 form a central "-sheet containing both 
parallel and antiparallel strands while "-strands 6 and 7 form a b-hairpin loop. These 
elements form a globular domain together with the first six helices. The remaining helices 
and "-strand 11 form the dimerization arm indicated in A. (Zhang et al. 2000)
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Hereditary Human Spherocytosis
Normal Physiology of the Red Blood Cell
 Erythrocytes develop from pluripotent hematopoietic stem cells  found in 
the bone marrow through a process  known as erythropoiesis. The first definite 
erythrocyte precursor is known as a pronormoblast that further develops into the 
nucleated normoblast. As  the normoblast develops it progressively shrinks and the 
cytoplasm becomes less basophilic and increasingly acidophilic due to the build 
up of hemoglobin. By the final form of the normoblast, the nucleus is pyknotic and 
the cell is  only about 5 microns in diameter. At this point, the normoblast loses its 
nucleus and leaves  the bone marrow as a reticulocyte. An alteration in the cell 
shape occurs outside the bone marrow and after one to two days the reticulocyte 
becomes a mature erythrocyte (Dacie and White 1949). Mature erythrocytes are 
about 7.5 microns in diameter and 2 microns thick. An erythrocyte will survive 
around 120 days in circulation before being removed and most of its  iron is recy-
cled. Each cell contains  high amounts of hemoglobin, making erythrocytes  well-
suited for the transport of oxygen to tissue throughout the body (Silbernagl and 
Despopoulos 88).
 Due to the lack of organelles  and its membrane skeleton, the erythrocyte is 
very deformable. The nature of blood is such that its  viscosity when passing 
through small arteries is  about 4 relative units, twice as  high as that of plasma. 
This viscosity increases in smaller vessels since the velocity of flow decreases, but 
red blood cells compensate by traversing capillaries in single file. The deformable 
nature of their membranes  allows them to pass  through safely despite the smaller 
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diameter of the capillaries (92) In capillaries closer to the diameter of the erythro-
cyte, the cell takes on a parachute-like shape (Figure 5A). In narrow capillaries 
around 4 microns in diameter, the most common shape is a torpedo shape (Figure 
5B) (Skalak and Branemark 1969).
 A
 B
Figure 5. Deformation of red blood cells
A: The parachute shape of In vivo erythrocytes traversing a 7 µm capillary with the cell 
on the left displaying the tail-flap appearance.
B: Red blood cells passing through 4 µm capillary adopt a U-shape or hollow torpedo 
shape.
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Pathophysiology of Hereditary Spherocytosis
 Hereditary Spherocytosis (HS) refers to a group of inherited hemolytic 
anemias  associated with defects in the erythrocyte membrane skeleton. The preva-
lence of HS is highest in northern Europe and North America, affecting about one 
in every 2000 people. Three fourths  of HS cases display an autosomal dominant 
inheritance pattern while the remaining cases have a more severe autosomal reces-
sive form. HS results from mutations affecting the proteins  involved in the 
spectrin-ankyrin-band 3 complex. Mutations in the ANK1 gene for ankyrin make 
up 50% of the autosomal dominant cases of HS while another 15-20% of cases  are 
due to a mutations in SLCA1, the gene for band 3. Other mutations that result in 
HS can be found in SPTA1, SPTB, and EPB42, the genes that encode for !-
spectrin, "-spectrin, and protein 4.2, respectively (Delaunay 2002). All of these 
mutations cause a disruption in the link between the erythrocyte cytoskeleton and 
the membrane, resulting in reduced membrane surface area, a decreased mem-
brane to surface ratio, and the formation of spherocytes  to compensate for these 
changes (Figure 6). These spherocytes end up trapped in the spleen where low pH, 
low glucose and adenosine triphosphate concentrations, contact with macrophages, 
and high local concentrations of oxidants deliver additional damage. The destruc-
tion of abnormal erythrocytes by the spleen is the main cause of hemolysis in HS 
(Perrotta et al. 2008)
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Figure 6. Scanning electron micrograph of red blood cells
(a): The normal biconcave shape of erythrocytes.
(b): Erythrocytes from a HS patient have spherical shape and smaller cell size. (Agre et 
al. 1982)
Complications and Therapies of HS
 Patients with HS can present with various symptoms such as anemia, sple-
nomegaly, and jaundice. HS is diagnosed based on the presence of spherocytes in 
peripheral blood smears, increased osmotic fragility, and a positive family history. 
The severity of the disease varies  from individual to individual with 20-30% of 
patients remaining asymptomatic due to compensation by increased erythropoie-
sis.  In most cases, the compensatory measures  taken by the body to match red cell 
destruction are outpaced, leading to chronic hemolysis (Kumar, Abbas, and Fausto 
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644). This state leads  to the formation of bilirubinate gallstones, which are the 
most common complication of HS. Gallstones  are found in 40-50% of patients in 
their second to fifth decade with a majority of cases in those between 10 to 30 
years of age. Co-inheritance of Gilbert’s Syndrome, the most common hereditary 
cause of increased bilirubin, increases the risk of developing cholelithiasis up to 
five-fold. Timely diagnosis, best done by ultrasonography, allows for quick treat-
ment to stem the possibility of biliary tract diseases like cholecystitis and cho-
lagnitis.
 Most patients also experience a few anemic crises in their lifetime. Hemo-
lytic crises are produced by events that lead to increased splenic destruction of red 
blood cells, as in the case of Epstein-Barr virus  infection. Cases are typically mild 
and punctuated by transient jaundice, splenomegaly, reticulocytosis, and anemia. 
Aplastic crises  are less common and are triggered by acute parvovirus infection. 
Parvovirus infects the bone marrow, killing red cell progenitors  and stopping red 
cell production for 1-2 weeks  until an immune response is mounted. Aplastic cri-
ses lead to severe anemia that requires in-hospital treatment and transfusion, and 
patients may face complications as serious  as  congestive heart failure or death. 
Megaloblastic crises  are rare and typically only found in underdeveloped countries 
where nutrition is  an issue. Since these cases are caused by folate deficiency, they 
can occur in patients with increased folate demand (e.g. pregnant women, chil-
dren, and patients recovering from an aplastic crisis) and can be treated with folate 
supplements. Rarely in cases of severe HS, patients can develop other manifesta-
tions such as leg ulcers, gout, chronic dermatitis, extramedullary hematopoietic 
16
tumors, hematological malignant diseases  (e.g. multiple myeloma and leukemia, 
and angioid streaks).
 Splenectomy is often beneficial to most patients with the treatment elimi-
nating the anemia and hyperbilirubinemia and reducing reticulocyte counts to 
near-normal levels. Splenectomy does involve risk and a serious long-term com-
plication is overwhelming infection with encapsulated bacteria, usually Strepto-
coccus pneumoniae. In some regions  of the world, fulminant parasitic infections 
can occur. Immunization, prophylactic use of penicillin, or early antibiotic treat-
ment can help reduce, but not eliminate, the incidence of postsplenectomy infec-
tion. Splenectomy is recommended between ages 6-9, as the risk of infection is 
higher in young children and the risk of cholelithiasis is higher in children over 10 
years old. An alternative to total splenectomy is partial splenectomy. Partial sple-
nectomy removes enough spleen to reverse anemia and relieve symptomatic sple-
nomegaly while still preserving the immune function of the organ (Perotta et al. 
2008). A laparoscopic approach to the procedure has been developed and a clinical 
study has been done to compare the outcome of a group of patients who underwent 
that procedure to patients  who underwent laparoscopic total splenectomy. Laparo-
scopic partial splenectomy is  associated with more pain, longer oral intake time, 
and a longer hospital stay than laparoscopic total splenectomy, but retained splenic 
function may outweigh these short-term disadvantages. Long-term results  of pa-
tient outcome have yet to be reported for this  more recent therapy (Morinis et al. 
2008). Other alternatives include near-total splenectomy and partial splenic em-
bolization, both of which prove safe and effective for the treatment of HS (Stoehr 
et al. 2005; Kimura et al. 2003).
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CHAPTER II
ELECTRON PARAMAGNETIC RESONANCE
Basic Principles of EPR
Origin of the EPR Signal
 Every electron possesses a magnetic moment, u, and an intrinsic spin angu-
lar momentum with a primary quantum spin number S (S = !) and a secondary 
magnetic component MS (MS = -!. !). Due its  magnetic moment, an electron will 
align itself either parallel (MS = -!) or antiparallel (MS = !) in the presence of an 
external magnetic field with strength B. These two states each have specific ener-
gies, known as the Zeeman effect, with the parallel alignment corresponding to the 
lower energy state and the antiparallel alignment corresponding to the higher en-
ergy state. If the direction is chosen to be along B, the two allowed energy states 
are:
E = −µzB = geβeMsB = ±12geβeB
where ge is the Zeeman (correction) factor for the free electron ge = 2.00232 and !e 
is  the Bohr magneton, which is a physical constant of the electronic magnetic 
moment
βe =
|e|!
2me
= 9.2740154(31)× 10−24JT−1
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Unpaired electrons  can move between the two electronic Zeeman levels by ab-
sorption or emission of electromagnetic radiation of energy h" if that energy 
matches the separation of "E, giving the fundamental resonance equation:
∆E = hν = geβeB
In addition to the external magnetic field, an unpaired electron is affected by the 
nearby nuclei of atoms, which have magnetic dipole moments that generate a local 
magnetic field . In EPR, the interaction between these species is called nuclear hy-
perfine interaction. For a spin label, the unpaired electron (S = !) interacts with 
the nitrogen nucleus  14N, which has  a primary quantum number I (I=1) and a sec-
ondary quantum number MI (MI = -1, 0, +1). In this case, the selection rules for 
EPR absorption ("MS = ±1 and "MI = 0) allow for three transition (Figure 7).
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Figure 7. Energy levels of system with S = ! and I =1
Energy levels and allowed EPR transitions at constant field for a system with S = ! and I 
= 1. Energy levels are represented with horizontal lines marked with MS and MI values. 
The allowed EPR transitions are indicated by the vertical arrows labeled k, l, and m. A 
simulated EPR field sweep spectrum depicting these transitions is shown on the right.
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 Two unpaired electrons in close proximity to each other interact either by 
orbital overlap, known as electron exchange interactions, or through space, known 
as electron-electron dipole interactions. For example, if the electron orbitals of two 
unpaired electrons overlap in a paramagnetic center of moderate size, the system 
will separate into a triplet (S = 1) and a singlet (S = 0) state. The electron-electron 
dipole interaction behaves  like anisotropic hyperfine interaction between elec-
tronic and nuclear magnetic dipoles.
 As with NMR, two relaxation processes exist in EPR. T1, the spin-lattice 
relaxation time, describes the time required for the redistribution of spin-
orientation states back to thermal equilibrium. Other relaxation processes such as 
spin diffusion are characterized by T2, the spin-spin relaxation time. These proc-
esses  have the effect of varying the relative energies of the spin levels rather than 
their lifetimes. For nitroxides, T2 is in the 100-nanosecond range while T1 is nor-
mally in the microsecond range at ambient temperature.
Spin Dynamics
 EPR lineshapes can be affected by any dynamic process in or around the 
paramagnetic center, such as hindered rotation, molecular tumbling, and chemical 
reaction. Lineshape broadening can classified as homogeneous or inhomogeneous 
broadening. Homogeneous broadening arises from a set of equivalent spins with 
identical spin parameters and local fields. Spin lifetime (T1), spin diffusion (T2), 
and dynamic processes contribute to homogeneous linewidth. Inhomogeneous 
broadening from nonequivalent spins is due to the variation of the external mag-
netic field and unresolved hyperfine structure.
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 Conventional EPR operates in the 1 to 100 GHz frequency range, making it 
sensitive dynamics  on the nanosecond time scale. Fast motions of less than 1 ns, 
such as side chain motions of surface residues, give rise to sharp spectra. Interme-
diate motions  of 1 to 10 ns, such as  the backbone motions  of surface exposed 
loops, lead to homogeneously broadened spectral features. Slow motions of 10 ns 
to 1 µs, such as the global tumbling of large globular proteins in solution, leads to 
the spectral features of the anisotropic magnetic interactions. Rigid motions that 
correspond to certain conformational changes and global uniaxial rotations of 
transmembrane proteins within the lipid bilayer result in powder specter in con-
tinuous wave EPR (CW-EPR) (Hustedt and Beth 1999). In biological systems, 
molecular motions can range from 10-14 s (bond vibration) to 10 s (local denatu-
ration). Saturation transfer EPR (ST-EPR) spectroscopy can be used for the slower 
motions to the ms time scale. In ST-EPR, one narrow region of the inhomogene-
ously broadened EPR signal is saturated. The recovery and spreading of the satura-
tion via spin diffusion is studied by monitoring secondary harmonic signals.
Pulsed EPR
 To help understand the complicated motions of a sample, it is advantageous 
to use a rotating coordinate system referred to as the rotating frame (Figure 8). In 
the presence of an external field, B, each electron spin magnetic moment under-
goes precession around the z direction at its Larmor frequency, #B. In the EPR ex-
periment, circularly polarized B1 with a microwave frequency of # is applied per-
pendicular to B, with #B = # at resonance. In a rotating coordinate system with 
angular frequency #, B1 appears stationary along the x-axis and the Larmor pre-
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cession around the z-axis  is  no longer visualized. The bulk magnetization, M, ro-
tates about the x-axis  and is tilted into the xy-plane at the tip angle $ =  |%eB1|tp, 
where %e is  the gyromagnetic ratio of an electron and tp is the length of time B1 is 
applied. In CW-EPR, where B1 maintains a constant amplitude with time, the spins 
are driven back and forth between states MS = ±!. Given an adequate T1 relaxa-
tion process, a population difference is  maintained and a net absorption signal is 
observed. In pulsed EPR, where tp is on the order of several nanoseconds, the exci-
tation amplitude is time dependent. Pulses are often labeled by their tip angles, for 
example a &/2 pulse corresponds to a rotation of M0 by &/2. Combining different 
pulses at different times can generate a plenitude of information regarding a spin 
system. Well developed pulsed techniques  include electron spin echo envelope 
modulation (ESEEM) and double electron electron resonance (DEER) also known 
as pulsed ELDOR (electron electron resonance).
z
B
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x
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Figure 8. Rotating frame in relation to lab frame
The Cartesian coordinates (xyz) represent the lab frame. The static magnetic field B lies 
along the z-axis. The oscillating magnetic field B1, perpendicular to B, rotates around the 
z-axis (azimuthal angle ') in the xy-plane at the angular frequency #. The rotating frame 
(x'y'z) also rotates at frequency #. The x'-axis aligns with B1.
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Applications of SDSL in EPR
Site-Directed Spin Labeling
 Spin labels, unlike free radicals, are chemically stable and thus useful in 
EPR experiments. One such agent, methanethiosulfonate spin label (MTSSL), is a 
pyrroline derivative with four methyl groups to protect the unpaired electron in the 
pn orbital of the nitroxide (Figure 9). Without these methyl groups, the nitroxides 
can be easily reduced to hydroxylamine in the presence of a reducing agent such 
as ascorbic acid. Nitroxides can be covalently bound to a number of agents rang-
ing from small molecules to certain components of macromolecules. In the case of 
site-directed spin labeling with MTSSL, the nitroxide binds to free cysteine resi-
dues.
MTSSL }
Side Chain 
Figure 9. The reaction of MTSSL with cysteine
The unsaturated spin label reacts with a free cysteine residue on a protein to generate the 
nitroxide side chain R1. Bond rotation angles (3, (4, and (5 that relate the spin label to 
the cysteine residue are defined. (Klug and Feix 2008)
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 The basic strategy of SDSL benefitted greatly from the development of mo-
lecular cloning and site-directed mutagenesis. The technique requires the substitu-
tion of all the native nondisulfide bonded cysteine residues  with either alanines or 
serines and then reintroducing a single cysteine mutation at the site of interest. The 
reactive SH group can then be modified by the introduction of a nitroxide spin la-
bel. The commercially available ethanethiosulfonate derivatives, such as MTSSL, 
are widely use to generate disulfide linked nitroxide side chains. There is much 
evidence to support that the introduction of these single cysteine mutations and 
spin labeling have minimal effect on the structure and function of the protein. The 
pairing of SDSL with EPR can provide previously unavailable information since it 
is  not limited by protein size nor by the optical properties of the sample. This 
technique is a versatile approach to providing local and global structural informa-
tion.
Side Chain Mobility
 The simplest information that can be obtained from an EPR spectrum con-
cerns spin label motion since the lineshape itself reflects rotational mobility. X-
band CW-EPR is sensitive to motions  in the nanosecond time scale. The dynamics 
of free spin label is described by the rotational correlation time ). With nitroxides, 
) measures the average lifetime of a particular spatial orientation of the nitrogen p 
orbital and its reciprocal is the rate of motion of the spin label (Columbus and 
Hubbell 2002). EPR lineshapes thus  reflect the rotational motions of different cor-
relation times (Figure 10). Free spin label in solution experiences a fast correlation 
time (~0.1 ns) and the resulting EPR spectra contains three sharp lines of ap-
25
proximately equal height. As the motion of the side chain is  slowed and the corre-
lation time lengthens, the peaks on the EPR spectra broaden. Since the signal in-
tensity is proportional to the amplitude and the square of the linewidth, the ampli-
tude decreases as the lines broaden.
Figure 10. The relation of correlation time and CW-EPR lineshapes
Simulated X-band CW-EPR lineshapes of a nitroxide spin label at different correlation 
times. The changes in EPR lineshape reflect changes in the rotational motion of the sam-
ple. The first derivative spectrum of the fast rotational motion () * 0) displays three 
sharp lines. As the rate of motion decreases and the correlation time increases, the spec-
trum broadens and becomes more complex. At the rigid limit () = +) the powder spec-
trum can be observed in a system of random oriented single crystals, where each experi-
ences highly anisotropic motion. (Klug and Feix 2008)
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 When the spin label is attached to a protein backbone, the side chain will be 
affected by the rotational diffusion of the protein, internal dynamic modes of the 
side chain, tertiary interactions with nearby moieties, and local backbone structure. 
For larger proteins and macromolecular assemblies, the overall rotation is too slow 
to affect the EPR spectra. The tumbling of small proteins (> ~15kDa), however, 
can affect the spectra. This contribution can be reduced by increasing solution vis-
cosity, for example, by adding 30% (w/w) sucrose to the sample (Mchaourab et al. 
1996). The side chain motion is the primary interest since it is  the motion that is 
affected by tertiary contacts and the local environment. A number of studies have 
shown that the flexibility of MTSSL is generally governed by the two bonds clos-
est to the nitroxide ring, (4 and (5 (Figure 9) (Langen et al. 2000; Columbus et al. 
2001). Even on a solvent exposed helix with no adjacent contacts, the hydrogen 
bond formed between the S, sulfur and the backbone C$ atom restricts the mobility 
about the first two bonds, limiting the internal motion of the R1 side chain to 
isomerizations around the (4/(5 dihedral angles (Langen et al. 2000). Therefore the 
motion of the spin label and the backbone fluctuations are linked.
 Tertiary contacts with nearby side chains have more significant effects  on 
EPR spectra. Spin labels with these interactions exhibit complex lineshapes and 
site buried in the core of a protein often display spectra approaching the rigid 
limit. Parameters regarding mobility can be attained from components of the spec-
tra, such as the peak-to-peak linewidth and the center linewidth. More detailed 
quantitative analysis  can be performed by simulating the EPR spectrum in order to 
obtain rotational correlation times and other order parameters.
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Solvent Accessibility
 The accessibility of the R1 side chain to the solvent provides a good deal of 
structural information about the protein. Since the power saturation technique util-
izes the fact that certain paramagnetic reagents  affect the relaxation rate of the spin 
label, it is a useful tool for studying solvent accessibility. When under nonsaturat-
ing conditions, the height of the spectral line increases linearly with the square 
root of the incident power, P!. As the microwave power increases, the sample can-
not relax fast enough and the relationship is no longer linear. At even higher 
power, the height of the spectral line decreases. When certain paramagnetic rea-
gents react with the spin label, the relaxation rate is increased and more power is 
able to be absorbed before saturation. The two main paramagnetic reagents typi-
cally used are O2, which is mainly found in the hydrophobic portion of the lipid 
bilayer, and nickel compounds such as nickel(II) ethylenediamine diacetate 
(NiEDDA), which are water soluble. Nitrogen is used to purge molecular oxygen 
from the sample as a control.
 R1 solvent accessibility is sensitive to the local environment since it has a 
large influence on the collision frequency between the nitroxide and the paramag-
netic reagent. The direct measure of the bimolecular collision rate between the 
spin label and the paramagnetic reagent is  the value "P!. P! is the power at which 
the height of the central linewidth is  half of its  unsaturated intensity. In the case of 
NiEDDA, the P! of the N2 control is subtracted from the P! in the presence of 
NiEDDA to give "P!. For a solvent-exposed residue, a high "P! value would be 
observed. In addition, secondary structure can be observed for a-helices  and b-
strands that experience amphipathic environments. An $- helix, for example, 
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would experience a "P! with a periodicity of 3.6 (Figure 11A) while a --strand 
would have an periodicity of 2 (Figure 11B). Since oxygen is  lipid-soluble, it can 
be used together with NiEDDA to study the depth of a residue within the lipid bi-
layer. The "P! for the two reagents would be the inverse of one another, with 
higher "P!(O2) and lower "P!(NiEDDA) indicating a residue found in the hydro-
phobic region of the membrane. Changes in O2 and NiEDDA accessibility can also 
be reflective of conformational changes. This  method has been useful for studying 
dynamic processes such as light activation of rhodopsin (Farrens et al. 1996) and 
gating of the mechanosensitive channel MscL (Perozo et al. 2002).
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Figure 11. Solvent accessibility of secondary structures
(a): A surface $-helix on a water soluble protein displays a pattern of NiEDDA accessibil-
ity  that repeats approximately  every 4th residue, following the 3.6 residue turn of a typi-
cal helix. 
(b): The solvent accessibility  of a surface --strand alternates between a high and low "P!, 
indicating solvent-exposed and buried residues, respectively. (Klug and Feix 2008)
Spin-Spin Distance
 The ability to make distance measurements between two spin labels is a 
rapidly developing field of EPR. CW-EPR can make measurements between 8 Å 
to 25 Å where the spin-spin interactions are larger than the inhomogeneous line 
broadening. Pulsed EPR techniques can cover distances from 17 Å to 80 Å. These 
distance measurements  can be used for many purposes, such as  monitoring con-
30
formational changes and developing structural models. Distance measurements 
depend on the dipolar coupling interaction between the unpaired electrons of the 
two spin labels. In CW-EPR, magnetic dipole interactions  result in line broadening 
and an accompanying decrease in signal amplitude. Quantitative analysis can be 
performed through a few different approaches (Altenbach et al. 2001; Steinhoff et 
al. 1997; Hustedt et al. 1997). The resolution of such methods depends on the 
flexibility of the R1 side chain, with highly immobilized spin labels giving a reso-
lution on the order of 0.1-0.2 Å (Hustedt et al. 1997).
 Pulse EPR techniques, like DEER, have a larger distance range that allow 
for greater applications. Since the dipole interactions at these distances are smaller 
than the inhomogeneous broadening, three strategies have been implemented to 
separate the dipole interactions. The first method involves refocusing all interac-
tions of an observer spin with a second unpaired electron in an echo experiment. 
The dipolar coupling is then reintroduced by an inversion pulse applied to the sec-
ond spin. The second method is to observe the double quantum coherence caused 
by the coupling of the two spins. The third method is to refocus  all interactions ex-
cept the coupling using a solid echo. These methods  provide the modulations be-
tween the electron spins  that can be analyzed to determine the distance between 
two labels.
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CHAPTER III
GENERAL EXPERIMENTAL METHODS
CW-EPR Measurements
 X-band (9.8 GHz) CW-EPR spectra were collected using a Bruker EMX 
spectrometer equipped with a TM110 cavity (BrukerBiospin, Billerica, MA) at 
room temperature. Samples were drawn into 50 µL glass capillaries (VWR, West 
Chester, PA) and sealed with Critoseal sealant (Fisher, Pittsburgh, PA).
Solvent Accessibility
 Solvent accessibility of individual spin-labeled residues was measured on 
samples diluted to 100 µM spin concentration in 20 nM NaH2PO4, 100 mM NaCl, 
pH 6.8. NiEDDA was added to a final concentration of 5 mM. Samples were 
purged of molecular oxygen by flowing nitrogen gas over the sample contained in 
a TPX capillary for 20 minutes prior to and during measurements. An ER4123D 
dielectric resonator was utilized for collection. A 20 Gauss scan of the central 
resonance line for each mutant was carried out using a 1 Gauss  modulation ampli-
tude of 100 kHz frequency. A total of 24 scans were separately recorded at micro-
wave powers ranging from 1 mW to 200 mW using a 1dB attenuation per step. 
Data were analyzed using Origin 6.1 software (OriginLab Corporation, Northamp-
ton, MA) by a non-linear least squares curve fitting of the spectral amplitude (A0) 
versus the square root of microwave power (P0) using the equation:
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A0 =
cΛ
√
P0
[1 + (21/! − 1)P0/P1/2]!
where A0 is the peak-to-peak amplitude of the first derivative spectrum, c is the 
instrumental proportionality constant, LAMBDA is the instrumental factor, P0 is 
the input power, ! is the lineshape adjustment parameter, and P! is  the half satura-
tion power. The NiEDDA accessibility was calculated by the following equation:
Ac(NiEDDA) =
P1/2(NiEDDA)− P1/2(N2)
∆H0
where Ac is the accessibility, P!(NiEDDA) is the half saturation power in the 
presence of 5 mM NiEDDA, P!(N2) is the half saturation power in the absence of 
NiEDDA, and "H0 is the central line width (Subczynski and Hyde 1981; Alten-
bach et al. 1989).
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CHAPTER IV
STRUCTURE OF CDB3 HEREDITARY SPHEROCYTOSIS VARIANT 
G130R: BAND 3 FUKUOKA
Introduction
 Hereditary spherocytosis (HS) is  familial hemolytic disorder clinically 
characterized by anemia, jaundice, and splenomegaly (See HS section for details). 
HS occurs in about 1 in every 2000 people. In HS, weakened “vertical” interac-
tions of the cytoskeleton result in membrane blebbing, leading to a decreased sur-
face area-to-volume and the cell becomes spherical. Spherocytes are less deform-
able and have increased osmotic fragility. These cells are unable to pass through 
the narrow cords of the spleen where they are removed from circulation and de-
stroyed, resulting in hemolytic anemia. Mutations causing to HS have been identi-
fied in the genes ANK1, SLCA1, SPTA1, SPTB, and EPB42 that encode for the 
proteins ankyrin, band 3, !-spectrin, "-spectrin, and protein 4.2, respectively. Mu-
tations in band 3 make up 15-20% of cases of HS.
 Band 3, also known as anion exchanger 1 (AE1), is  one of three members 
of CL-/H3CO- anion exchangers. Band 3 has two functionally distinct domains, a 
transmembrane and cytoplasmic domain. The transmembrane domain of band 3 
(tdb3) makes up the C-terminal end of the protein is  responsible for the transport 
of anions across the erythrocyte membrane. The N-terminal cytoplasmic domain 
of band 3 (cdb3) serves as an organization center for a number of cytoplasmic and 
membrane-associated proteins at the lipid bilayer (Lux et al. 1989).
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 Numerous band 3 mutations have been identified in patients  with HS. A 
study of patients with HS showed that patients with frameshift and nonsense muta-
tions lacked band 3 mRNA in their reticulocytes, leading to an overall decrease in 
band 3 expression. Point mutations, on the other hand, displayed comparable lev-
els of normal and mutant band 3 (Jarolim et al. 1996). Many point mutations in the 
transmembrane domain of band 3 have been shown to lead to defective trafficking 
of the protein to the erythrocyte membrane (Dhermy et al. 1999; Quilty and Re-
ithmeier 2000; Toye et al. 2008). In the cytoplasmic domain of band 3, three muta-
tions have been identified in association with HS. These mutants (E40K, G130R, 
and P327R) still form dimers at the erythrocyte membrane and have no significant 
changes in stability, suggesting the mutations interfere with the binding of cdb3 to 
ankyrin or protein 4.2 (Bustos and Reithmeier 2006). Indeed, past studies have 
linked the P327R mutation to decreased protein 4.2 binding at the erythrocyte 
membrane (Jarolim et al. 1992). To better understand the mode of this disruption, 
site-directed spin labeling was used in conjunction with electron paramagnetic 
resonance and double electron-electron resonance in order to study the structural 
changes in the P327R mutant. While the P327R mutation does not disrupt the di-
mer, it does alter the packing of the C-terminal end of helix 10 in the dimerization 
arm and elicit spectral changes in the N-terminal portion of helix 10 and some 
residues  in "-strand 11. These results, taken together with previous studies, indi-
cate a potential site for interaction between protein 4.2 and cdb3 (Zhou et al. 
2007).
 Of the remaining two mutants, E40K is located at the unresolved N-
terminus of cdb3 while G130R is  located on the surface at the start of helix 2. The 
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G130R mutant provides  an interesting target for the study of structural changes 
and protein-protein interactions. Clinically, G130R results in a mild form of HS 
with only a 9.3% reduction in band 3 content in the red blood cell. The protein 4.2 
deficiency was more substantial with the protein 4.2 levels at 45% that of normal 
cells  (Inoue et al. 1998). To examine the structural changes caused by this muta-
tion, site-directed spin labeling (SDSL) studies using a combination of CW-EPR 
and power saturation experiments  were conducted on a cysteineless cdb3 back-
ground with or without the G130R mutation. In this chapter, data shows that sub-
stitution of arginine in place of glycine at position 130 results  in local structural 
changes. The mutation does not affect the dimerization region, but does alter the 
packing of surface !-helix 2 comprised of residues 128-141.
Experimental Methods
Cloning and Site-directed Mutagenesis
 The wildtype construct of residues 1-379 of AE1, designated pZZ3_WT, 
was readily available from previous work. The G130R mutation was introduced 
into this construct using a pair of primers:
 Forward 5' GAC CTC CCT GGC TAG AGT GGC CAA CCA 3'
 Reverse 5' TGG TTG GCC ACT CTA GCC AGG GAG GTC 3'
and designated as pZZ13_WT. The cysteineless mutants (pZZ3 and pZZ13) and 
single cysteine mutants  were constructed by using the QuikChange Site-Directed 
Mutagenesis  Kit (Stratagene, La Jolla, CA). The sequences of all mutants were 
checked by DNA sequencing.
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Protein Preparation and On-Column Labeling
 Plasmids were transformed into BL21 Gold (DE3) E. coli competent cells 
(Stratagene, La Jolla, CA). The auto-induction protocol developed by Dr. F. Wil-
liam Studier (Brookhaven National Laboratory) was used for the expression of 
cdb3 (Studier 2005). Overnight starter cultures  were grown in PAG at 37°C and 
200 µL of the starter cultures were used to inoculate 200 mL ZYP-5052 for over-
night auto-induction (14 hours). Saturation (A600 = 4.8~7.0) was usually reached 
by 10 hours at 37°C. Additional incubation for 4 hours ensured maximum lactose 
auto-induction. His-tagged cdb3 purification was  carried out using Ni-NTA resin 
as described by the manufacturer (Qiagen, Valencia, CA). Protein concentration 
was determined by UV absorption at 280 nm using an extinction coefficient of 
33,000 M-1cm-1. Purity of the expressed proteins was checked by SDS-PAGE. 
Single cysteine mutants were spin-labeled with a 10-fold molar excess  of 1-oxyl-
2,2,5,5-tetramethyl-#3-pyrroline-3-methyl methanethiosulfonate spin label 
(MTSSL; Toronto Research Chemicals, North York, ON Canada) in the dark at 
room temperature for 2 hours and then overnight at 4°C in a buffer containing 50 
mM NaH2PO4, 300 mM NaCl, and 200 mM imidazole, pH 8.0. Unbound label 
was removed from all samples by diluting and reconcentrating four times (~ 1:50 
v/v) in an Amicon Ultra-4 Centrifugal Filter Device (30 kDa nominal molecular 
weight limit, Millipore, Bedford, MA) using a buffer containing 20 mM NaH2PO4, 
100 mM NaCl, 1 mM EDTA, pH 6.8.  All EPR measurements were collected with 
the spin-labeled samples in this  buffer at pH 6.8. Spin-labeled protein concentra-
tions were determined using double integration of CW-EPR measurements with a 
37
1 mM 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (Tempol) standard. 3D 
structures were visualized using MacPyMOL (DeLano Scientific LLC, San Carlos, 
CA).
Experimental Results
G130R Mutant Dimer Remains Unperturbed
 The crystal structure of cdb3 depicted a dimeric conformation at pH 4.8 
(Zhang et al. 2000) that was confirmed by SDSL studies of the solution structure 
at neutral pH (Zhou et al. 2005). The dimerization arms span from residue 304 to 
357 and consist of "-strand 11 situated between !-helixes 9 and 10. These ele-
ments interlock the two monomers through extensive backbone and side chain in-
teractions (Zhang et al. 2000). To analyze the global structure and oligermerization 
of the G130R mutant, site directed spin labeling coupled with electron paramag-
netic resonance (SDSL-EPR) was employed with and without the G130R muta-
tion. Single cysteine mutants  of residues both near the dimer interface and distrib-
uted around the peripheral globular domain were generated and spin labeled with 
MTSSL, designated as side chain R1 (Figure 12) (Berliner et al. 1982; Langen et 
al. 2000).
 The spectra of most sites  were showed little difference between the G130 
and R130 backgrounds  for all sites  save two. The spectra of 105R1 showed only a 
small difference in lineshape while the fast motion of residue 277, found on the 
surface of the globular domain, is slightly dampened in the G130R mutant. Similar 
side chain mobility, lineshape components, and splitting was found for the remain-
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ing sites studied- the highly mobile lineshape of 142R1, which is found at the start 
of the loop connecting helix 2 and helix 3; the immobilized lineshape of 290R1, 
which is situated on the interior surface of helix 7; the slightly mobile 312R1, 
which is  located on the !-helix of the dimerization arm in the space between the 
two monomers; and the marked broadening and three-peak splitting of 108R1 due 
to dipolar coupling of the spin labels between the two monomers (Figure 12).
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Figure 12. CW-EPR characterization of residues around the dimer interface
Top panel: Ribbon structure of cdb3 dimer with dimerization arms shown in light green 
and R130 in yellow stick. C! atoms of spin-labeled residues are shown as spheres: 105 
(dark purple), 108 (wheat), 142 (light blue), 277 (green), 290 (magenta), 312 (orange).
Bottom panel: EPR lineshapes of G130 cdb3 (black line) and R130 cdb3 (red line) with 
black arrows indicating spectra with observable differences. The 120 Gauss sweep spec-
tra are normalized to the same amplitude for ease of comparison.
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 Further SDSL-EPR studies were performed on residues  339-345, found 
along the length of helix 10. These sites  form part of the dimerization arm and fol-
low an i to i + 3 pattern. Lineshapes are remarkably similar between the G130 and 
R130 backgrounds with each residue maintaining its original side chain mobility 
following the introduction of the G130R mutation (Figure 13). Two of these sites, 
340R1 and 342R1 (Figure 14), were selected for double electron-electron reso-
nance experiments, carried out by Dr. Eric Hustedt (Vanderbilt University, Nash-
ville, TN). Results of these experiments showed no change in the intramolecular 
distances  between either pair of residues (Figure 14). Together, these findings 
show the dimer interface remains unchanged in the G130R mutant.
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Figure 13. EPR characterization of residues  339-345 on the dimerization arms
Top panel: The structure and location of residues 339-345 (pink) on the ribbon diagram 
of the cdb3 dimer (blue and red).
Bottom panel: The CW-EPR spectrum at each position is normalized to the same ampli-
tude and with a total scan width of 100 Gauss.
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Figure 14. DEER characterization of residues 340 and 342 on the dimerization arms
Top panel: Set up for DEER experiments with residue 340 (cyan stick) and residue 342 
(purple stick) spin labeled. Residue 340 is located on the surface while residue 342 is bur-
ied within the dimer interface. The dotted black line represents the intramolecular dis-
tances measured for each experiment.
Bottom panel: Analysis of DEER results for G130 cdb3 (blue) and R130 cdb3 (red) 
shows no significant change in either the magnitude or distribution of distances for site 
340 (left) and 342 (right).
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Structural Rearrangement in the !2 Surface Helix
 While residue 130 faces out from the surface, making it less likely to be in-
volved in the internal packing of the protein and the $, % dihedral angles common 
to arginine are also agreeable to the helical secondary structure, the G130R muta-
tion inserts a residue with very different steric and electrostatic properties. As 
such, the substituted arginine residue might disrupt or alter the normal folding of 
the surface helix. The local effects  of the G130R mutation were studied by placing 
10 R1 side chains along the N-terminal half of helix 2 (Figure 15). The purity of 
samples was checked with SDS-Page and concentrations determined by double 
integration of EPR signals.
 Helix 2 of cdb3 is  comprised of residues 128 to 141. CW-EPR spectra of 
single cysteine mutants from residue 127 to residue 137 showed differences  in the 
lineshapes for residues 131-136 when comparing the normal cdb3 to the G130R 
mutant (Figure 15). The altered lineshapes indicate a change in the side chain mo-
bilities of these residues for a portion of the G130R population. Residues 131, 132, 
135, and 136 are found on the internal surface of helix 2 and residue 133 faces the 
solvent. Each of these residues show only slight changes  in species populations 
with the G130R mutation, while residue 134 shows a more notable change. Fol-
lowing the introduction of the G130R mutation, a significant population of slower-
moving species  appears in addition to the typically fast-moving, solvent exposed 
species. Accessibility of residues 127 to 137 with the water soluble paramagnetic 
agent NiEDDA was measured using a dielectric resonator (Farahbakhsh et al. 
1992; Hubbell et al. 1996). Solvent accessibility of the G130 and R130 back-
grounds are plotted as a function of residue number (Figure 16). The accessibility 
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plot displays  that the approximate periodicity of 4 characteristic of an a-helix is 
maintained in the G130R mutant. The frequency of collision between the spin la-
bel and paramagnetic agent is  similar for these residues, suggesting that the overall 
tertiary environment of these residues  remains the same with one side of the helix 
on the surface and the other facing the hydrophobic core. These results show that 
the backbone of helix 2 retains both its secondary structure and orientation.
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Figure 15. EPR characterization of residues 127-137 on helix 2
Top panel: Residues 127-129 and 137 (pink) and residues 131-136 (green) are displayed 
on a ribbon diagram of the cdb3 dimer. R130 is shown in yellow stick. The green spheres 
coincide with the residues that showed a shift in the EPR spectra from the wild type.
Bottom panel: 100 Gauss scans of residues 127-137 with normalized amplitudes. Arrows 
indicate spectrum that show changes between the G130 (black) and R130 (red) samples.
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Figure 16. NiEDDA accessibility of the R1 side chain from residues 127-137
Black squares represent the NiEDDA accessibility of residues 127-137 of the wt-cdb3. 
Red circles represent the NiEDDA accessibility of residues 127-137 of the G130R mu-
tant.
Discussion
 As with many mutations linked to human disease, pathogenic mutations in 
AE1 can alter protein function in a number of different ways including abnormal 
biosynthesis levels, incorrect trafficking, misfolding, and functional defects. AE1 
mutations are responsible for HS, SAO, and distal renal tubular acidosis (dRTA). 
The importance of cdb3’s  role as an organization center for various  protein-protein 
interactions  related to membrane stability and deformability is  evidenced by the 
mutations in this  domain that lead to diseases  (HS, SAO) associated with mem-
brane defects. The crystal structure of cdb3 (Zhang et al. 2000) and solution struc-
ture of cdb3 (Zhou et al. 2005) provide a means to deduce the structural signifi-
cance of mutation sites that result in abnormal red blood cell shape but do not alter 
47
band 3 expression. Substitution of the glycine at position 130 with arginine (desig-
nated as Band 3 Fukuoka) occurs at the solvent-exposed surface of helix 2, a part 
of the peripheral globular domain (Inoue et al. 1998). Sedimentation equilibrium, 
circular dichromism, and thermal denaturation experiments showed the G130R 
mutant maintained the same oligomerization state, secondary structure, and stabil-
ity as the wild-type protein, indicating smaller scale structural changes (Bustos and 
Reithmeier 2006).
 SDSL-EPR experiments, capable of analyzing of such changes  to the envi-
ronment and positioning of individual residues  (Klug and Feix 2008), were util-
ized for the comparison of side chain mobility and solvent accessibility at various 
sites on both the wild type and G130R mutant. These locations  were distributed 
through the globular domain, the dimer interface, or adjacent to the site of the mu-
tation. The latter group of sites are immediately in the vicinity of the mutation site 
on helix 2. 
 As shown in the crystal structure, G130 is  found on the solvent-accessible 
surface near the start of helix 2. Our data is in agreement with previous studies 
showing the global structure and dimer interface remain unchanged by the G130R 
mutation. With regards  to the local backbone structure, arginine is unlikely to dis-
rupt the structure of helix 2 by its  substitution due to its !, & angles giving it a 
high propensity for involvement in right-handed helices. The electrostatic and 
steric qualities, on the other hand, are very different from glycine. Arginine is a 
long, flexible side chain with a positive charge, making it hydrophilic, whereas 
glycine is small and hydrophobic. As a solvent-exposed residue, such a substitu-
tion should not be unfavorable.
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 Replacing the glycine with an arginine would alter the local electrostatic 
field and that could cause the slight shift in the side chain interactions of nearby 
residues  along helix 2. Simple inspection of the spectra reveals that while the spec-
tral shape of both 131R1 and 132R1, the decrease in peak heights indicate slowed 
side chain motion. More notable are the changes  in the spectra for 133R1 and 
134R1. These two residues are both on the solvent-exposed side of the helix and 
the overall shape of their spectra reflect as  such. The differences in the spectra, 
more specifically the appearance of a peak more representative of slow motion in 
the spectrum for 134R1 and an opposite shift in 133R1, are indicative of changes 
in the tertiary contacts for these residues. While the R1 side chain of 133 becomes 
more mobile, the R1 side chain for 134 increases the number of tertiary contacts. 
Residue 136 is buried on the hydrophobic side of the helix and its spectral appear-
ance, while different between the wild type and mutant species, still approaches 
the rigid limit. 137R1 is the last side chain to exhibit a change in its  spectrum, dis-
playing an increased population with slower movement as well as a slight change 
in the central line. While the side chain mobility of these sites alters in some man-
ner, the solvent accessibility does not. These data suggest that the helix does not 
undergo any manner of rotation though the side chain interactions change. This 
work highlights the use of SDSL-EPR in evaluating small structural changes and 
provides further information towards understanding the molecular pathophysiol-
ogy of hereditary spherocytosis.
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Further Work
 Though these changes seen in the EPR data for the G130R mutation are 
subtle, the structural differences still result in altered protein-protein interactions, 
most notably is  the loss of protein 4.2. Since protein 4.2 is believed to bind in the 
region of the dimerization arm, it is  more likely that helix 2 influences the cdb3-
ankyrin interaction, which stabilizes  the binding of protein 4.2 with cdb3 (Rybicki 
et al. 1995). Ankyrin has been shown to interact with cdb3 on the surface opposite 
the dimer interface and modeling using the protein docking program 3D-Dock 
proposes the contact surface to include the !-helix 3, the loops  connecting the first 
and second "-strands, the fifth "-strand and !-helix 2 that follows, along with "-
strands six to ten and !-helix six (Figure 17) (Chang and Low 2003; Michaely et 
al. 2002). Further evidence for this surface as the ankyrin binding interface comes 
from site-directed fluorescence labeling (SDFL) that showed residues near helix 2 
experienced a change in exposure upon binding of ankyrin to normal cdb3 (Figure 
18 and Table 1) (Zhou thesis).
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Figure 17. Model of the interaction between cdb3 and ankyrin
Ribbon diagram of the computer generated docking of ankyrin to cdb3. Ankyrin (green) 
interacts with the peripheral of cdb3’s globular domain. The proposed binding site on 
cdb3 is displayed in dark purple while the rest  of the dimer is displayed in gray. (Mi-
chaely et al. 2002)
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Figure 18. Ankyrin-binding interface mapped on the cdb3 dimer
Surface rendering of the cdb3 dimer structured. The colored legend bar displays the 
linear-gradient scale of blue or red shift  of the maximum emission wavelength ('max) 
upon ankyrin binding. Residue 130 is displayed in green. Residues tested on the same 
face of the globular domain are colored according to the values of #'max (Table 1).
Table 1. 'max shift upon ANK_D34 of cdb3
Residue # 127 133 137 148 151 152 155 156
'cdb3 (nm) 536 531 526 531 521 524 527 503
'cdb3+ANK_D34 (nm) 516 527 514 531 512 499 525 499
#'max = 'cdb3 - 'cdb3+ANK_D34 
(nm)
20 4 12 0 9 25 2 4
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 Since the G130R mutation is  located on the surface-exposed side of helix 2, 
it provides  an opportunity to better understand the interaction between cdb3 and 
ankyrin. For this purpose, we plan to use SDSL-EPR experiments in order to study 
the role of helix 2 in the binding of ankyrin. CW-EPR experiments with cdb3 in 
the presence of ankyrin can provide a glimpse at the tertiary contacts to residues 
along helix 2 and how these contacts may change in the G130R mutant. Quantita-
tive analysis of spin label mobility could also be useful in gauging the interaction 
between specific residue side chains  on cdb3 with ankyrin. Perhaps more informa-
tive, however, would be the use of NiEDDA accessibility studies to examine the 
solvent exposure of cdb3 upon binding ankyrin. For wild type cdb3, one would 
expect that the surface residues of helix 2 would become less  exposed if they are 
involved in the interface with ankyrin. Structural rearrangements upon binding, for 
example if the helix rotates, can also be observed based on the pattern of solvent 
accessibility. Comparing the changes with the wild type cdb3 and the G130R mu-
tant in both the presence of ankyrin can provide information on how the small 
structural changes seen in this work affect helix 2 as part of the binding surface.
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